CSIRO offers the full spectrum of bioconjugation services to couple diverse targeting biomolecules.
Share
Our bioconjugation capabilities can be tailored to meet your unique research objectives based on our comprehensive know-how. CSIRO offers additional in-house expertise in synthesis (including GMP manufacturing of biologics), in-depth characterisation, purification, assay development and testing, process development, and technology transfer.
Our bioconjugation services include targeting biomolecules (e.g., proteins, aptamers, peptides, etc.) to chelators (for theranostics), cytotoxic drugs, fluorescent tags, bespoke polymers, drug delivery systems, or surfaces (such as biosensors and medical implants).
Did you know?
CSIRO can perform bioconjugation chemistry in CSIRO’s National Vaccine and Therapeutics Lab strengthening Australia’s ability to deliver GMP bioconjugates for use in Australian clinical trials.
We are working with SMEs, Biotechnology and Pharmaceutical companies, and universities to deliver on a range of bioconjugation projects.
Working with us – Our capabilities in small molecule drug discovery and development
We partner with small and large companies, government and industry in Australia and around the world. Explore how our science and technology can help your organisation.
Find out how we can help you and your business. Get in touch using the form below and our experts will get in contact soon!
CSIRO will handle your personal information in accordance with the Privacy Act 1988 (Cth) and our Privacy Policy.
Thank you
We have received your enquiry and will reply soon.
We're Sorry
The contact form is currently unavailable. Please try again later. If this problem persists, please call us with your enquiry on 1300 363 400 or +61 3 9545 2176. We are available from 9.00 am to 4.00 pm AEST Monday - Friday.
